Veterinary Medicines

Api-Bioxal 632.7 mg/g bee-hive powder

Authorised
  • Oxalic acid dihydrate
Download as PDF

Product identification

Medicine name:
Api-Bioxal 632.7 mg/g bee-hive powder
API-Bioxal 886 mg/g polvere per alveare
Active substance:
  • Oxalic acid dihydrate
Target species:
  • Honey bee
Route of administration:
  • In-hive use

Product details

Active substance and strength:
  • Oxalic acid dihydrate
    886.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Bee-hive powder
Withdrawal period by route of administration:
  • In-hive use
    • Honey bee
      • Honey
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AG03
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:
  • Multilayer polyester-Aluminium-Polyethylene laminated bags, heat sealed, containing 350 g of powder.
  • Multilayer polyester-Aluminium-Polyethylene laminated bags, heat sealed, containing 175 g of powder.
  • Multilayer polyester-Aluminium-Polyethylene laminated bags, heat sealed, containing 35 g of powder.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Chemicals Laif S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chemifarma S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104384
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0132/001
Concerned member states:
  • Austria
  • Bulgaria
  • Croatia
  • France
  • Ireland
  • Norway
  • Portugal
  • Romania
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 11/11/2024
Download
Italian (PDF)
Published on: 2/03/2022
Download